BAC share‑price dip, valuation and insider / institutional flows
Key Questions
What is the current status of Bank of America (BAC) stock price?
BAC closed at $50.06, up 1.38% and outpacing the market on April 1 with +4.42% gains from upgrades and deals. YTD it's down 9% but recovering, with fwd P/E at 11.43-12.7x and P/TB 1.79x, deemed undervalued by S&P among Big4 banks.
What are the analyst price targets for BAC?
Moderate Buy consensus PT is $59.54, implying ~20% upside; UBS trimmed to $62 from $67, JPM to $57.5 from $61.5, Goldman Sachs raised to $58 from $57 maintaining Buy. Morgan Stanley trimmed to $61 citing higher-risk environment.
Why is BAC considered undervalued?
Hartnett and Buffett view BAC as cheap; S&P rates it undervalued among Big4 with fwd P/E 11.43-12.7x and P/TB 1.79x. It's highlighted as a top long-term stock and best value in Buffett's portfolio, with median PT $61.
What institutional flows are supporting BAC?
Institutions added 6.42M shares QoQ, with Vanguard +23M and Strategic Blueprint +3k; others like Mitsubishi UFJ +204k, SteelPeak, Aprio increased holdings. Myriad sold 26k, but overall inflows noted amid $40B buyback tracking.
How has Buffett positioned in BAC?
Buffett cut his stake by 50%, yet BAC remains a key holding viewed as the best value in his portfolio. Analysts remain optimistic with PTs up to $71 previously, now trimmed but still bullish on scale vs. PNC stability.
How does BAC compare to peers like PNC?
BAC shows uptrend vs. PNC's scale/stability focus; S&P undervalued rating stands out among Big4. US bank stocks followed broader market down in March, but BAC up 5.1% post-upgrades on capital strength.
What recent analyst actions on BAC?
JPM lowered PT to $57.5 from $61.5; GS to $58 from $57 Buy; Morgan Stanley to $61. Upgrades spotlight capital strength, payouts; trend analysis shows positive momentum into April.
What drives BAC's recovery YTD?
YTD -9% recovery driven by upgrades/deals, institutional buying like Vanguard's large addition, and $40B buyback. Outpacing market on key days, with bullish long-term views despite PT trims amid higher-risk environment.
$50.06 +1.38% outpacing mkt (Apr1 +4.42% upgrades/deals; YTD -9% recovery; fwd P/E 11.43-12.7x disc/P/TB 1.79; S&P undervalued Big4); Moderate Buy PT $59.54 ~20% with UBS trim to $62 (from $67)/JPM $57.5 (from $61.5); Hartnett/Buffett cheap; insto +6.42Mn QoQ (Vanguard +23M, Strategic Blueprint +3k); Buffett 50% cut; uptrend vs PNC scale/stability. Track 13Fs/$40B buyback.